Edition:
United States

North China Pharmaceutical Co Ltd (600812.SS)

600812.SS on Shanghai Stock Exchange

5.87CNY
22 Sep 2017
Change (% chg)

¥-0.05 (-0.84%)
Prev Close
¥5.92
Open
¥5.91
Day's High
¥5.92
Day's Low
¥5.86
Volume
3,835,551
Avg. Vol
9,294,718
52-wk High
¥7.60
52-wk Low
¥5.34

Chart for

About

North China Pharmaceutical Company. Ltd is a China-based company principally engaged in the production and distribution of pharmaceuticals. The Company's main products are classified as penicillin, cephalosporin, vitamin and other products, including bulk pharmaceuticals, finish preparations and healthcare products, among... (more)
No analyst recommendations are available for .

Overall

Beta: 1.00
Market Cap(Mil.): ¥9,556.52
Shares Outstanding(Mil.): 1,630.81
Dividend: 0.02
Yield (%): 0.34

Financials

  Industry Sector
P/E (TTM): -- 31.67 16.08
EPS (TTM): -- -- --
ROI: -- 15.12 14.60
ROE: -- 16.35 14.03

BRIEF-North China Pharmaceutical to issue 290 mln yuan 4-year bonds

* Says to issue 290 million yuan ($43.97 million) 4-year bonds

Sep 21 2017

BRIEF-North China Pharmaceutical to pay A shares annual div for FY 2016 on Aug. 25

* Says it will pay cash dividend of 0.02 yuan(before tax)/share for 2016 to shareholders of record on Aug. 24

Aug 20 2017

BRIEF-North China Pharmaceutical issues 2017 2nd series super short-term debentures worth 500 mln yuan

* Says it issues 2017 the second series super short-term debentures worth 500 million yuan, with coupon rate of 5.08 percent and maturity date on Jan. 29, 2018

Aug 03 2017

BRIEF-North China Pharmaceutical issues 210 mln yuan worth of corporate bonds

* Says it issues 210 mln yuan worth of 2017 public offering corporate bonds

Aug 02 2017

BRIEF-North China Pharmaceutical sets coupon rate for 2017 corporate bonds at 6.5 pct

* Says it sets coupon rate for 2017 corporate bonds at 6.5 percent

Jul 31 2017

BRIEF-North China Pharmaceutical to issue up to 500 mln yuan 4-year bonds

* Says to issue up to 500 million yuan ($74.10 million) 4-year bonds

Jul 25 2017

BRIEF-North China Pharmaceutical's unit receives GMP certificate

* Says co's pharmacy unit received goods manufacture practice (GMP) certificate from Hebei Food and Drug Administration, for its sterile APIs (amoxicillin/sulbactam), with the valid period is until June 22, 2022

Jul 17 2017

BRIEF-North China Pharma gets approval to issue 2.0 bln yuan debt financing instruments

* Says it gets approval to issue 2.0 billion yuan ($294.94 million) debt financing instrument

Jul 14 2017

BRIEF-North China Pharmaceutical unit receives GMP certificate

* Says co's unit received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration for its powder injection production line

Jul 12 2017

BRIEF-North China Pharmaceutical issues 2017 1st tranche super short-term financing notes worth 1 bln yuan

* Says it issued 2017 1st tranche super short-term financing notes worth 1 billion yuan with a term of 270 days and interest rate of 5.3 percent

Jul 10 2017

Earnings vs. Estimates